Found: 9
Select item for more details and to access through your institution.
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 617, doi. 10.1007/s00262-003-0498-0
- By:
- Publication type:
- Article
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 614, doi. 10.1007/s00262-002-0328-9
- By:
- Publication type:
- Article
Very low frequencies of human normal CD34<sup>+</sup> haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 2, p. 409, doi. 10.1046/j.1365-2141.2002.03261.x
- By:
- Publication type:
- Article
Identification of a WT1 protein-derived peptide, WT1<sub>187</sub>, as a HLA-A*0206-restricted, WT1-specific CTL epitope.
- Published in:
- Microbiology & Immunology, 2008, v. 52, n. 11, p. 551, doi. 10.1111/j.1348-0421.2008.00069.x
- By:
- Publication type:
- Article
Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).
- Published in:
- 2003
- By:
- Publication type:
- journal article
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The lck promoter-driven expression of the Wilms tumor gene WT1 blocks intrathymic differentiation of T-lineage cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.
- Published in:
- International Journal of Hematology, 2003, v. 77, n. 2, p. 56, doi. 10.1007/BF02983241
- By:
- Publication type:
- Article